(Q36217858)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

3

Edina Bugyik

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

9

Zsuzsa Schaff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

2

Katalin Dezső

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

5

Sándor Paku

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Szofia Hajósi-Kalcakosz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Zoltán Pávai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Judit Halász

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Krisztina Schlachter

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Péter Nagy

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

18 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.

8 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Polycombing the genome: PcG, trxG, and chromatin silencing

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436720

Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC

22 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1746-1596-7-86

Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1746-1596-7-86

CD10 immunostaining of bile canaliculi in liver biopsies: change of staining pattern with the development of cirrhosis

21 January 2018

1 reference

12 December 2020

Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma

1 reference

12 December 2020

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

1 reference

12 December 2020

Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics

1 reference

12 December 2020

Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma

1 reference

12 December 2020

Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastomas

1 reference

12 December 2020

Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance

1 reference

12 December 2020

Identifiers

DOI

10.1186/1746-1596-7-86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

8 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

PubMed publication ID

22809481

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22809481%20AND%20SRC:MED&resulttype=core&format=json